Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Magnetic nanoparticles (MNPs) represent a class of non-invasive imaging agents that have
been developed for magnetic resonance (MR) imaging. These MNPs have traditionally been …
been developed for magnetic resonance (MR) imaging. These MNPs have traditionally been …
Chemical design of nanoparticle probes for high‐performance magnetic resonance imaging
Synthetic magnetic nanoparticles (MNPs) are emerging as versatile probes in biomedical
applications, especially in the area of magnetic resonance imaging (MRI). Their size, which …
applications, especially in the area of magnetic resonance imaging (MRI). Their size, which …
Evolution of drug delivery systems: From 1950 to 2020 and beyond
H Park, A Otte, K Park - Journal of Controlled Release, 2022 - Elsevier
Modern drug delivery technology began in 1952 with the advent of the Spansule® sustained-
release capsule technology, which can deliver a drug for 12 h after oral administration …
release capsule technology, which can deliver a drug for 12 h after oral administration …
Regulatory effects mediated by ulvan oligosaccharide and its zinc complex on lipid metabolism in high-fat diet-fed mice
Y Chi, Z Wu, C Du, M Zhang, X Wang, A Xie… - Carbohydrate …, 2023 - Elsevier
Obesity-induced lipid metabolism disorders are risk factors for hyperlipidemia,
atherosclerosis, and non-alcoholic fatty liver disease. Seaweed oligosaccharides and Zn …
atherosclerosis, and non-alcoholic fatty liver disease. Seaweed oligosaccharides and Zn …
[HTML][HTML] Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy
AA Khalafallah, AE Dennis - Journal of pregnancy, 2012 - hindawi.com
Nutritional iron-deficiency anaemia (IDA) is the most common disorder in the world, affecting
more than two billion people. The World Health Organization's global database on anaemia …
more than two billion people. The World Health Organization's global database on anaemia …
Structure, chemistry, and pharmacokinetics of intravenous iron agents
BG Danielson - Journal of the American Society of Nephrology, 2004 - journals.lww.com
All intravenous (IV) iron agents are colloids that consist of spheroidal iron-carbohydrate
nanoparticles. At the core of each particle is an iron-oxyhydroxide gel. The core is …
nanoparticles. At the core of each particle is an iron-oxyhydroxide gel. The core is …
Physicochemical properties of ferumoxytol, a new intravenous iron preparation
VS Balakrishnan, M Rao, AT Kausz… - European journal of …, 2009 - Wiley Online Library
Background Intravenous iron is a critical component of anaemia management. However,
currently available preparations have been associated with the release of free iron, a …
currently available preparations have been associated with the release of free iron, a …
A prospective randomised controlled trial of a single intravenous infusion of ferric carboxymaltose vs single intravenous iron polymaltose or daily oral ferrous sulphate …
AA Khalafallah, A Hyppa, A Chuang, F Hanna… - Seminars in …, 2018 - Elsevier
Iron deficiency anaemia (IDA) is the most common nutritional deficiency affecting pregnant
women worldwide. This study aims to compare the efficacy and safety of a newly available …
women worldwide. This study aims to compare the efficacy and safety of a newly available …
When is high-dose intravenous iron repletion needed? Assessing new treatment options
D Gozzard - Drug design, development and therapy, 2011 - Taylor & Francis
High doses of intravenous iron have a role in the treatment of a number of clinical situations
associated with iron deficiency, iron deficiency anemia, and blood loss. In the presence of …
associated with iron deficiency, iron deficiency anemia, and blood loss. In the presence of …
Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations
Intravenous iron therapy is used to treat anemia associated with chronic kidney disease. The
chemical structures of parenteral iron agents have not been characterized in detail, and …
chemical structures of parenteral iron agents have not been characterized in detail, and …